TranS1 plans IPO to get $80.5 million
Published: Wed, Jul. 25, 2007 12:00AM
Modified Wed, Jul. 25, 2007 02:49AM
E-Mail
Print
tool name
closeWILMINGTON -- TranS1, a Wilmington-based medical device company focused on spine treatments, filed to raise as much as $80.5 million in an initial public offering of stock.
The company was founded in May 2000 and had 63 employees as of June 30, according to a filing submitted to the Securities and Exchange Commission on Tuesday. TranS1 has developed a less-invasive procedure to treat degenerative disc disease, which affects the lower back.
If the IPO is successful, TranS1 plans to use the money raised to pay for further testing and marketing of its products.
More Business
All rights reserved. This copyrighted material may not be published, broadcast or redistributed in any manner.
Get it all with convenient home delivery of The News & Observer.
The News & Observer is pleased to be able to offer its users the opportunity to make comments and hold conversations online. However, the interactive nature of the internet makes it impracticable for our staff to monitor each and every posting.
Since The News & Observer does not control user submitted statements, we cannot promise that readers will not occasionally find offensive or inaccurate comments posted on our website. In addition, we remind anyone interested in making an online comment that responsibility for statements posted lies with the person submitting the comment, not The News and Observer.
If you find a comment offensive, clicking on the exclamation icon will flag the comment for review by the administrators, we are counting on the good judgment of all our readers to help us.
